Patent · US Active

Benzimidazole derivative

US8455650B2 · kind B2 · utility

0Cited by

1References

1Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Wolgang Broeder · Ingelheim am Rhein, DE
Rainer Sobotta · Ingelheim am Rhein, DE

Key dates

Filing date	Jan 17, 2012
Grant date	Jun 4, 2013
Priority date	—
Expiry date	Jan 17, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to a process for preparing the compound of formula 1, a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.